A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says.
Nemolizumab (Nemluvio) relieved itchiness within two days for three times as many patients as a placebo, researchers reported Tuesday in the Journal of the European Academy of Dermatology and Venereology.
The drug also helped twice as many eczema patients sleep better within a couple of days, researchers said.
"These new data reinforce our understanding of nemolizumab's rapid onset of action in relieving itch and, in turn, improving sleep in patients living with atopic dermatitis and prurigo nodularis," researcher Dr. Christophe Piketty said in a news release. He's program head of therapeutic dermatology for the Swiss pharma company Galderma.
Related
